SWOG clinical trial number
CTSU/EA8153

Cabazitaxel with Abiraterone Versus Abiraterone Alone Randomized Trial for Extensive Disease Following Docetaxel: The CHAARTED2 Trial

Open
Phase
II
Abbreviated Title
Rando Exten Dis Cabazitaxel w/ Abi vs. Abi following Docetaxel- CHAARTED2
Status Notes
This study is open to accrual effective February 8, 2018.
Activated
02/08/2018

Research committees

Genitourinary Cancer

Treatment

Prednisone Abiraterone Acetate Cabazitaxel

Other Clinical Trials

SWOG Clinical Trial Number
S1806

Phase III Randomized Trial of Concurrent Chemoradiotherapy with or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer.

Research Committee(s)
Genitourinary Cancer
Activated
04/19/2019
Accrual
2%
Open
Phase
III
SWOG Clinical Trial Number
S1802
SWOG Clinical Trial Number
CTSU/EA8153